Диссертация (1154915), страница 20
Текст из файла (страница 20)
//JACC. – 2009. - №54. – Р. 1154–1161.142. Pritchett A.M. Diastolic dysfunction and left atrial volume: a populationbased study. /Pritchett A.M., Mahoney D.W., Jacobsen S.J., Rodeheffer R.J., KaronB.L., Redfield M.M. //JACC. – 2005. - №45. – Р. 87–92.143. Raine D. Effect of catheter ablation on quality of life in patients with atrialfibrillation and its correlation with arrhythmia outcome. /Raine D., Langley P.,Shepherd E. at al. // Open Heart.
– 2015. - №2. – Р. e000302.144. Rambihar S. Heart rate is associated with increased risk of majorcardiovascular events, cardiovascular and all-cause death in patients with stablechronic cardiovascular disease: an analysis of ONTARGET/TRANSCEND./Rambihar S., Gao P., Teo K., Bohm M., Yusuf S., Lonn E.
//Circulation. - 2010. №122. - A12667.145. ReiffelJ.A.Is arterial stiffness a contributing factor to atrial fibrillation in patients with hypertension? A preliminary investigation. Am J Hypertens. – 2004. №17(3). – Р. 213-216.146. Rekovets О. Influence of combination different dose lercanedipine withdiltiazem in patients with mild to moderate arterial hypertension on central bloodpressure and pulse wave velocity.
/Rekovets О., Sirenko Y. , Dobrokhod A. et al.//JASH. - 2015. - №9(4). – Р. e26147. Reynolds M.R . Quality of Life in Atrial Fibrillation: Measurement Toolsand Impact of Interventions. / Reynolds M.R., Ellis E., Zimetbaum P. // JCardiovasc Electrophysiol. – 2008. - №19(7). – Р. 762–768.148. RobertsonJ.I. Diuretics,potassiumdepletionandtheriskofarrhythmias. Eur Heart J.
– 1984. - № 5 (Suppl A). – Р. 25-28.121149. Roman M.J. Central pressure more strongly relates to vascular disease andoutcome than does brachial pressure: the Strong Heart Study. /Roman M.J.,Devereux R.B., Kizer J.R.et al. // J Hypertens. – 2007. - № 50. – Р. 197-203.150. Rosca M.
Left atrial function: pathophysiology, echocardiographicassessment, and clinical applications. /Rosca M., Lancellotti P., Popescu B.A.,Pierard L.A. //Heart. - 2011. - № 97. - Р.1982-1989.151. Sa Cunha R. Association between high heart rate and high arterial rigidity innormotensive and hypertensive subjects. /Sa Cunha R., Pannier B., Benetos A. etal.// J Hypertens. – 1997. - №15. - Р. 1423–30.152. Saksena S.Cardiovascular outcomes in the AFFIRM Trial (AtrialFibrillation Follow-Up Investigation of Rhythm Management). An assessment ofindividual antiarrhythmic drug therapies compared with rate control withpropensity score-matched analyses.
/Saksena S., Slee A., Waldo A.L. et al.// JACC.-2011. - № 58 (19). - Р.1975-1985.153. Santos B.S. Impaired left atrial function in heart failure with preservedejection fraction. /Santos B.S., Kraigher-Krainer E., Gupta D.K. et al. //European Jof Heart Failure. - 2014. - №16. – Р.1096–1103.154. Savelieva I.Quality of life in patients with silent atrial fibrillation.
/SavelievaI., Paquette M., Dorian P. et al. //Heart. – 2001. - №85. – Р. 216-217.155. Schaer B.A. Risk for incident atrial fibrillation in patients who receiveantihypertensive drugs: a nested case-control study. /Schaer B.A., Schneider C.,Jick S.S. at al. //Ann Intern Med. – 2010. - №152(2). – Р.
78-84.156. Schoonderwoerd B.A. Electrical and structural remodeling: role in thegenesis and maintenance of atrial fibrillation. /Schoonderwoerd B.A., Van GelderI.C., Van Veldhuisen D.J., Van den Berg M.P., Crijns H.J. // Prog Cardiovasc Dis.– 2005. - №48. Р. - 153– 168.157. Schotten U. The role of atrial dilatation in the domestication of atrialfibrillation.
/ Schotten U., Neuberger H.R., Allessie M.A. //Prog Biophys MolBiol. – 2003. - №82(1-3). – Р. 151-162.158. Schron E.B. Quality of Life in Older Patients With Atrial Fibrillation.122/Schron E.B., Jenkins L.S.//Am J Geriatr Cardiol. – 2005. - №14(2). – Р. 87-90.159.
Shigetoh Y.. Higher heart rate may predispose to obesity and diabetesmellitus: 20-year prospective study in a general population. /Shigetoh Y., AdachiH., Yamagishi S. et al. //Am J Hypertens. – 2009. - №22. – Р. 151–155.160. Shlomai G. Assessment of Target Organ Damage in the Evaluation andFollow-Up of Hypertensive Patients: Where Do We Stand? /Shlomai G., Grassi G.,Grossman E., Mancia G. //The Journal of Clinical Hypertension.
– 2013. - №15(10). – Р. 742-747.161. Singh B.N. Morbidity and mortality in cardiovascular disorders: impack ofreduced heart rate. JCardiovascPharmacolTher.- 2001. - № 6. – Р. 313-331.162. Soanker, R. Effect of beta-1-blocker, nebivolol, on central aortic pressureand arterial stiffness in patients with essential hypertension./R. Soanker, NaiduM.U., Raju S.B., Prasad A.K., Rao T.R.//Indian J Pharmacol. – 2012. - №44(3). -Р.407-411.163. Spach,M.S.
Mechanism of origin of conduction disturbances in aginghuman atrial bundles: experimental and model study. / M.S. Spach, J.F. Heidlage,P.C. Dolber, R.C. Barr. // Heart Rhythm. – 2007. - №4. – Р. 175–185.164. Spencer, K.T Effects of aging on left atrial reservoir, conduit, and boosterpump function: a multi-institution acoustic quantification study. / K.T. Spencer, V.Mor-Avi, J. Gorcsan et al.// Heart. – 2001. - №85. – Р. 272–277.165. Stefanadis, C.
Aortic function in arterial hypertension determined bypressure-diameter relation: effects of diltiazem./ C. Stefanadis, J. Dernellis, C.Vlachopoulos, C. Tsioufis et al.// Circulation. – 1997. - №96. - Р.1853–1858.166. Su, H.M. Effects of heart rate on brachial-ankle pulse wave velocity andankle-brachial pressure index in patients without significant organic heart disease./H.M. Su, K.T. Lee, C.S. Chu et al. // Angiology. – 2007. - №58.
- Р. 67-74.167. Sutton-Tyrrell, K. Elevated aortic pulse wave velocity, a marker of arterialstiffness, predicts cardiovascular events in well-functioning older adults./ K.Sutton-Tyrrell, S.S. Najjar, R.M. Boudreau et al.// Circulation. - 2005. - №111. Р.3384–3390.123168. Tenekecioglu, E. Disturbed Left Atrial Function is Associated withParoxysmal Atrial Fibrillation in Hypertension.
/ E. Tenekecioglu, F. VatanseverAgc, O.A. Ozluk et al.//Arq Bras Cardiol. - 2013.169. Tenekecioglu, E. Disturbed Left Atrial Function is Associated withParoxysmal Atrial Fibrillation in Hypertension. / E. Tenekecioglu, F. Vatansever,O.A. Ozluk et al. // Arq Bras Cardiol.
– 2014. - №102(3). – Р. 253-262.170. Testa, M.A. Assessment of quality-of-life outcomes./ M.A. Testa, D.C.Simonson.// N Engl J Med. – 1996. - №334. - Р.835—840.171. Thomas, L. Compensatory changes in atrial volumes with normal aging: isatrial enlargement inevitable? / L. Thomas, K. Levett, A. Boyd, et al.// J Am CollCardiol. – 2002.
- №40(9). – Р. 1630-1635.172. Thomas, L. Abnormalities of left atrial function after cardioversion: an atrialstrain rate study. / L. Thomas, T. McKay, K. Byth et al.// Heart. – 2007. - №93. –Р. 89-95.173. Tomiyama,H.baPWV/cfPWVCollaborationGroup.Synergisticrelationship between changes in the pulse wave velocity and changes in the heartrate in middle-aged Japanese adults: a prospective study. / H.
Tomiyama, H.Hashimoto, H. Tanaka et al.// J Hypertens. – 2010. - №28. – Р. 687–694.174. Triposkiadis, F., Left atrial mechanical function in the healthy elderly: newinsights from a combined assessment of changes in atrial volume and transmitralflow velocity./F. Triposkiadis, K. Tentolouris, A. Androulakis et al.// J Am SocEchocardiogr.
– 1995. - №8(6). – Р. 801-809.175. Tsang, T. Prediction of cardiovascular outcomes with left atrial size: isvolume superior to area or diameter?/ T. Tsang, W. Abhayaratna, M. Barnes et al.//JACC. – 2006. - №47. - Р.1018-1023.176. Tsang, T.S. Left atrial volume as a morphophysiologic expression of leftventricular diastolic dysfunction and relation to cardiovascular risk burden. / T.S.Tsang, M.E.
Barned, B.J. Gersh, K.R. Bailey, J.B. Seward// Am J Cardiol. - 2002.– №90. - Р. 1284–1289.177. Tucay E.S. Left Atrial Volume and Left Atrial Function as Predictor of124Postoperative Atrial Fibrillation. /E.S. Tucay.//Phil Heart Center J. - 2012. – Р. 1-6.178. Van der Hooft, C.S.
Drug-induced atrial fibrillation./ C.S. Van der Hooft, J.Heeringa, G. Van Herpen et al.//J Am Coll Cardiol. – 2004. -№44(11). Р. 21172124.179. Van Gelder, I.C. A comparison of rate control and rhythm control in patientswith recurrent persistant atrial fibrillation. / I.C. Van Gelder, V.E. Hagens, H.A.Bosker et al.// N Engl J Med. – 2002. - №347(23). - Р. 1834-1840.180. Vasan, R.S. Doppler transmitral flow indexes and risk of atrialfibrillation(the Framingham Heart Study)./ R.S. Vasan, M.G.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
